A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK
Part of paid clinical trials in Gilbert, Arizona.
- Sponsor
- Kodiak Sciences Inc
- Study ID
- NCT06556368
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
- Wet Age-related Macular Degeneration
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tarcocimab tedromer — DRUGIntravitreal injection
- Tabirafusp tedromer — DRUGIntravitreal injection
- Aflibercept — DRUGIntravitreal injection
Study Details
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (Wet) Age-related Macular Degeneration (wAMD)
Key Dates
- Start date
- Aug 23, 2024
- Status verified
- Apr 2026
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 675 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Tarcocimab tedromer 5 mg (KSI-301)Intravitreal injection of tarcocimab tedromer once every 4 weeks for 4 monthly doses followed by individualized dosing every 4 to 24 weeks.
- Experimental: Tabirafusp tedromer 5 mg (KSI-501)Intravitreal injection of tabirafusp tedromer once every 4 weeks for 4 monthly doses followed by every-8-week dosing with additional individualized dosing (up to monthly dosing)
- Active Comparator: Aflibercept 2 mgIntravitreal injection of aflibercept once every 4 weeks for 3 monthly doses followed by every-8-week dosing
Primary Outcome Measure
Best corrected visual acuity (BCVA) [ Time Frame: Week 48 ]
Locations (71)
Find similar trials in Gilbert, AZ
By research site
Related Studies
- Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMDPHASE3 · Recruiting · AbbVie · Phoenix, Arizona
- MMP-9 Inhibition for Recalcitrant Wet AMDPHASE2 · Recruiting · University of Iowa · Iowa City, Iowa